It promotes angiogenesis, the formation of new blood vessels, which accelerates nutrient and oxygen delivery to healing tissues
Additional GLP-1 receptor agonist risks include pancreatitis (severe, persistent abdominal pain requires urgent medical attention), gallbladder disease (cholelithiasis and cholecystitis), and risk of dehydration potentially leading to acute kidney injury, particularly during treatment initiation
Another category of anti-cancer peptides is peptide antagonists which can preferentially bind to a known receptor [121, 122]
Side effects The most common side effect is mild pain at the site of injection
For those with limited or no sun exposure, this injection offers an effective and rapidly absorbed solution
Semaglutide oral tablets demonstrated CV safety by meeting the primary endpoint of non-inferiority for the composite MACE endpoint